Delivery Order SPE2DB22D2206-SPE2DB25FFY18
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,279.55 firm fixed-price delivery order is for 4566564553 ! ONTRUZANT 150 MG VIALS, with a period of performance through November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,027.60, is for the delivery of ONTRUZANT 150 MG VIALS, a medical product. The contract has a firm fixed price pricing type and a completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,212.42, is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2025 and is structured as a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $10,566.04 Firm Fixed Price Delivery Order is for the provision of ONTRUZANT 420 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order (DO) valued at $42,275.51 with a firm fixed price pricing type. The contract is for the supply of the drug product ONTRUZANT 150 MG VIALS, with a period of performance through May 14, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $14,060.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ONTRUZANT 420 MG VIALS to be delivered by January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract falls under a larger indefinite delivery contract (IDC) awarded solely to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,312.50, is for the delivery of ONTRUZANT 150 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of February 7, 2025. The contract is not designated with a set-aside and appears to be a part of a larger Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFW46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONTRUZANT 420 MG VIALS, a medical product, with a ceiling value of $16,677.42. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 28, 2025. Amerisourcebergen holds a significant Indefinite...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $34,823.14 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of the pharmaceutical product ONTRUZANT 420 MG VIALS, with a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award, with an ID of SPE2DB22D2206 and SPE2DB24FFD26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $41,532.58 firm fixed-price delivery order is for the supply of ONTRUZANT 420 MG VIALS, a pharmaceutical product. The contract has a completion date of January 19, 2024 and was awarded on January 18, 2024. This contract is not designated with a set-aside requirement, indicating open competition....